Skip to main content

  • 3-Year COAPT Follow-Up Shows Sustained MitraClip Benefits

    • Posted: 02/22/2021
    • Author:

      Natalie Morrison, CRTonline.org

    Heart failure (HF) patients with functional mitral regurgitation (MR) given transcatheter mitral valve repair (TMVr) with MitraClip continued to see benefits over those on guideline-directed medical therapy (GDMT) alone at 36 months in the COAPT study.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details